186 related articles for article (PubMed ID: 31308209)
1. Risk of Cancer in 767 Patients with Giant Cell Arteritis in Western Norway: A Retrospective Cohort with Matched Controls.
Brekke LK; Fevang BS; Diamantopoulos AP; Assmus J; Esperø E; Gjesdal CG
J Rheumatol; 2020 May; 47(5):722-729. PubMed ID: 31308209
[TBL] [Abstract][Full Text] [Related]
2. Survival and death causes of patients with giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study.
Brekke LK; Fevang BS; Diamantopoulos AP; Assmus J; Esperø E; Gjesdal CG
Arthritis Res Ther; 2019 Jun; 21(1):154. PubMed ID: 31238961
[TBL] [Abstract][Full Text] [Related]
3. Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study.
Brekke LK; Diamantopoulos AP; Fevang BT; Aβmus J; Esperø E; Gjesdal CG
Arthritis Res Ther; 2017 Dec; 19(1):278. PubMed ID: 29246164
[TBL] [Abstract][Full Text] [Related]
4. Factors predicting death and cancer in patients with giant cell arteritis in Western Norway 1972-2012: a retrospective observational cohort study.
Brekke LK; Assmus J; Fevang BS
Front Med (Lausanne); 2023; 10():1243791. PubMed ID: 37746078
[TBL] [Abstract][Full Text] [Related]
5. Performance of the 2022 ACR/EULAR giant cell arteritis classification criteria for diagnosis in patients with suspected giant cell arteritis in routine clinical care.
Molina-Collada J; Castrejón I; Monjo I; Fernández-Fernández E; Torres Ortiz G; Álvaro-Gracia JM; de Miguel E
RMD Open; 2023 Apr; 9(2):. PubMed ID: 37094980
[TBL] [Abstract][Full Text] [Related]
6. Incidence Trends and Mortality of Giant Cell Arteritis in Southern Norway.
Andersen JB; Myklebust G; Haugeberg G; Pripp AH; Diamantopoulos AP
Arthritis Care Res (Hoboken); 2021 Mar; 73(3):409-414. PubMed ID: 31909871
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Performance of a Temporal Artery Biopsy for the Diagnosis of Giant Cell Arteritis in Japan-A Single-center Retrospective Cohort Study.
Oiwa H; Ichimura K; Hosokawa Y; Araki K; Funaki M; Kawashima M; Mihara H; Kimura N
Intern Med; 2019 Sep; 58(17):2451-2458. PubMed ID: 31118402
[TBL] [Abstract][Full Text] [Related]
8. Is temporal artery biopsy essential in all cases of suspected giant cell arteritis?
Grossman C; Barshack I; Bornstein G; Ben-Zvi I
Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-84-9. PubMed ID: 26016755
[TBL] [Abstract][Full Text] [Related]
9. Vasculitis distribution and clinical characteristics in giant cell arteritis: a retrospective study using the new 2022 ACR/EULAR classification criteria.
Andel PM; Diamantopoulos AP; Myklebust G; Haugeberg G
Front Med (Lausanne); 2023; 10():1286601. PubMed ID: 38020143
[TBL] [Abstract][Full Text] [Related]
10. Cancer preceding giant cell arteritis: a case-control study.
Kermani TA; Schäfer VS; Crowson CS; Hunder GG; Ytterberg SR; Matteson EL; Gabriel SE; Warrington KJ
Arthritis Rheum; 2010 Jun; 62(6):1763-9. PubMed ID: 20191583
[TBL] [Abstract][Full Text] [Related]
11. Giant cell arteritis and vascular disease-risk factors and outcomes: a cohort study using UK Clinical Practice Research Datalink.
Li L; Neogi T; Jick S
Rheumatology (Oxford); 2017 May; 56(5):753-762. PubMed ID: 28077689
[TBL] [Abstract][Full Text] [Related]
12. Performance of the new 2022 ACR/EULAR classification criteria for giant cell arteritis in clinical practice in relation to its clinical phenotypes.
Narváez J; Estrada P; Vidal-Montal P; Nolla JM
Autoimmun Rev; 2023 Oct; 22(10):103413. PubMed ID: 37598876
[TBL] [Abstract][Full Text] [Related]
13. Malignancy risk in patients with giant cell arteritis: a population-based cohort study.
Kermani TA; Schäfer VS; Crowson CS; Hunder GG; Gabriel SE; Ytterberg SR; Matteson EL; Warrington KJ
Arthritis Care Res (Hoboken); 2010 Feb; 62(2):149-54. PubMed ID: 20191512
[TBL] [Abstract][Full Text] [Related]
14. The Incidence and Predictors of Solid- and Hematological Malignancies in Patients with Giant Cell Arteritis: A Large Real-World Database Study.
Dar L; Ben-Shabat N; Tiosano S; Watad A; McGonagle D; Komaneshter D; Cohen A; Bragazzi NL; Amital H
Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34300046
[TBL] [Abstract][Full Text] [Related]
15. Incidence of Severe Infections and Infection-Related Mortality During the Course of Giant Cell Arteritis: A Multicenter, Prospective, Double-Cohort Study.
Schmidt J; Smail A; Roche B; Gay P; Salle V; Pellet H; Duhaut P
Arthritis Rheumatol; 2016 Jun; 68(6):1477-82. PubMed ID: 26815885
[TBL] [Abstract][Full Text] [Related]
16. Infections Are Associated With Increased Risk of Giant Cell Arteritis: A Population-based Case-control Study from Southern Sweden.
Stamatis P; Turkiewicz A; Englund M; Jönsson G; Nilsson JÅ; Turesson C; Mohammad AJ
J Rheumatol; 2021 Feb; 48(2):251-257. PubMed ID: 32414956
[TBL] [Abstract][Full Text] [Related]
17. Malignancies in Giant Cell Arteritis: A Population-based Cohort Study.
Stamatis P; Turesson C; Willim M; Nilsson JÅ; Englund M; Mohammad AJ
J Rheumatol; 2020 Mar; 47(3):400-406. PubMed ID: 31154410
[TBL] [Abstract][Full Text] [Related]
18. Mortality among Patients with Giant Cell Arteritis: A Large-scale Population-based Cohort Study.
Ben-Shabat N; Tiosano S; Shovman O; Comaneshter D; Shoenfeld Y; Cohen AD; Amital H
J Rheumatol; 2020 Sep; 47(9):1385-1391. PubMed ID: 31839591
[TBL] [Abstract][Full Text] [Related]
19. Concomitant association of giant cell arteritis and malignancy: a multicenter retrospective case-control study.
Deshayes S; Liozon E; Chanson N; Sacré K; Moulinet T; Blanchard-Delaunay C; Espitia O; Groh M; Versini M; Le Gallou T; Kahn JE; Grobost V; Humbert S; Samson M; Mourot Cottet R; Mazodier K; Dartevel A; Campagne J; Dumont A; Bienvenu B; Lambert M; Daumas A; Saadoun D; Aouba A; de Boysson H;
Clin Rheumatol; 2019 May; 38(5):1243-1249. PubMed ID: 30617596
[TBL] [Abstract][Full Text] [Related]
20. Patients with giant cell arteritis have a lower prevalence of diabetes mellitus: A systematic review and meta-analysis.
Ungprasert P; Upala S; Sanguankeo A; Warrington KJ
Mod Rheumatol; 2016; 26(3):410-4. PubMed ID: 26381748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
